在X-Waiver消除后,由临床医生专业的布普伦诺芬处置
相关实验视频
Updated: Sep 11, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Elizabeth M Stone1, Fangzhou Xie2, Jennifer Miles1
1Rutgers Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
取消X豁免增加了为阿片类药物使用障碍处方布普伦诺芬的临床医生人数. 然而,患者的收益是有限的,除了行为健康外,大多数专业领域的收益有所下降.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生政策 公共卫生政策
- 医疗保健服务研究 医疗服务研究
背景情况:
- 对阿片类药物使用障碍的布普伦诺芬处方的X-豁免要求构成了治疗获取障碍.
- 取消X豁免旨在减少这些障碍,并改善布普伦诺啡的可访问性.
研究的目的:
- 检查X-豁免消除对布普伦诺啡分发的影响.
- 分析不同临床专业的布普伦诺芬处方模式的变化.
主要方法:
- 利用了从2021年5月到2024年12月的IQVIA纵向处方数据.
- 进行了中断时间序列分析,以评估接受布普伦诺芬的临床医生和患者每月计数的变化.
- 根据临床医生的专业分层分析.
主要成果:
- 消除X豁免与所有专业的布普伦诺芬发行临床医生的数量显著增加相关.
- 除了行为健康医生之外,在消除后总体上观察到接受布普伦诺芬的患者数量显著下降.
- 对于初级保健提供者来说,布普伦诺芬患者的月率下降,但在政策变化后,行为健康医生的月率放缓.
结论:
- 虽然X豁免消除促进了临床医生的参与布普伦诺芬处方,但对患者数量的整体影响有限.
- 政策变化在不同的临床医生专业中产生了不同的影响,突出显示了治疗扩展的复杂性.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Elimination: The Concept of Clearance
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug Abuse and Addiction: Pharmacological Phenomena
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...

